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Chemistry, Go¨ttingen, GermanyABSTRACT The morphological features of a-synuclein (AS) amyloid aggregation in vitro and in cells were elucidated at the
nanoscale by far-field subdiffraction fluorescence localization microscopy. Labeling AS with rhodamine spiroamide probes
allowed us to image AS fibrillar structures by fluorescence stochastic nanoscopy with an enhanced resolution at least 10-fold
higher than that achieved with conventional, diffraction-limited techniques. The implementation of dual-color detection,
combined with atomic force microscopy, revealed the propagation of individual fibrils in vitro. In cells, labeled protein appeared
as amyloid aggregates of spheroidal morphology and subdiffraction sizes compatible with in vitro supramolecular intermediates
perceived independently by atomic force microscopy and cryo-electron tomography. We estimated the number of monomeric
protein units present in these minute structures. This approach is ideally suited for the investigation of the molecular mecha-
nisms of amyloid formation both in vitro and in the cellular milieu.INTRODUCTIONProtein aggregation is a key event in a number of human
neuropathies characterized by the presence of amyloid
structures in brain tissue, assembled from monomeric pro-
tein units aggregated into fibrils with a cross-b secondary
structure (1). Among them, Parkinson’s disease (PD) is
the most common motor neurodegeneration and has been
linked to the aggregation of a-synuclein (AS), a small
(~15-kDa) presynaptic, natively unfolded protein (2).
Amyloid aggregates of AS are found in the cytoplasm of
dopaminergic neurons in the midbrain (substantia nigra)
of individuals affected with PD, and the clinical symptoms
of the disease correlate with neuronal loss. However, the
complex, probably manifold, mechanisms responsible for
cytotoxicity are yet to be elucidated (3,4). In vitro investiga-
tions have generally portrayed amyloid protein aggregation
as a nucleation-polymerization process, according to which
monomers first associate into oligomeric species (nucleation
phase), which seed the formation of self-propagating mature
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0006-3495/12/04/1598/10 $2.00tangled aggregates (5). The most recent investigations on
cells point to oligomers as the primary injurious species,
acting to induce mitochondrial dysfunction, impair protein
quality control, and interfere with synaptic function (4,6).
The mature aggregates may actually play a neuroprotective
role, i.e., by depleting the cellular milieu of the more
dynamic, toxic intermediates (3).
The visualization in situ of oligomeric intermediates, and
of amyloid structures in general, is fundamental to under-
standing the underlying mechanisms and factors that trigger
and modulate the steps leading to fibrillation, and thus also
to understanding the interplay between protein aggregation
and loss of cellular homeostasis (7). The inherent nature of
the targets poses technical difficulties. On the one hand, the
AS oligomers described in the literature generally consist of
structures <40 nm in size, although we have reported, in
a parallel communication, the formation of supramolecular
intermediates that approach 0.5 mm in diameter (8). In
contrast, mature fibrils (prepared in vitro) are several mm
long but only ~10 nm in diameter (9). The ultrastructure
and morphological features of the AS amyloid species
have been investigated at high resolution using atomic force
microscopy (AFM) (9–11), electron microscopy (EM), and,
most recently, cryo-electron tomography (cryo-ET) (8).
These techniques are limited to the observation of surface
topography, in the case of cells, and generally require fixa-
tion and sectioning (EM). The transient early stages of
aggregation may be particularly susceptible to loss during
the latter procedures.
In view of these considerations, different fluorescence
microscopic techniques offer significant advantages for
imaging aggregation reactions. Numerous probes have
been developed for this purpose (12–16). In our own studiesdoi: 10.1016/j.bpj.2012.03.010
Fluorescence Nanoscopy of Amyloid 1599of AS aggregation, we have relied on protein-bound small
organic dyes and quantum dots for visualizing the location
and state of the protein (17–22). Dynamic properties were
assessed with the functional recombinant mutant AS
(AS-C4) bearing a tetracysteine tag binding the fluorogenic
biarsenical ligands FlAsH and ReAsH (22). In situ micros-
copy of molecular translational mobility using fluorescence
recovery after photobleaching and of local molecular
density using confocal fluorescence anisotropy (CFA) re-
vealed a high mobility of free protein. In contrast, AS in
larger aggregates was 80% immobile, whereas a small frac-
tion with an apparent diffusion constant of ~0.04 mm2/s was
attributed to smaller, associated forms of AS-C4 and to
exchange between mobile species and immobile aggregates.
The spatial correlations between anisotropy and intensity
also suggested the presence of small aggregates not detect-
able by conventional fluorescence imaging alone.
The main limitation of far-field fluorescence imaging, the
finite spatial resolution imposed by the optical diffraction
barrier (>~200 nm), has been overcome in recent years
with the development of superresolution far-field fluores-
cence microscopies (23–25). A common principle shared
by many of the currently employed strategies is the switch-
ing of a probe between dark (nonemitting) and bright
(emitting) states. The switching either is performed at
deterministic positions, with the spatial distribution of the
probe controlled, as in the so-called targeted nanoscopies
(e.g., STED, RESOLFT), or is allowed to occur at random
positions, which are then computed precisely (to ~10–
50 nm) in what is known as stochastic nanoscopy, or fluores-
cence localization microscopy (26–28), e.g., PALM,
STORM, GSDIM, and variants thereof. In particular, the
stochastic strategies such as PALM entail 1), random activa-
tion (switching on) of individual molecules; 2), registration
of the emission signal in a wide-field image; 3), computa-
tional localization of the emission centroids, which can be
accomplished with nanometer accuracy and precision to
a degree dependent on the number of detected photons,
dipole orientation, aberrations, and background; 4), deple-
tion (by inherent photobleaching or photoreversal) of the
observed molecules; and 5), repetition of steps 1–3 so as
to randomly access another set of probe molecules. The
superresolution image is generated from the cumulative
spatial coordinates acquired in a large number of such
cycles recorded in a long sequence of images.
The role of the fluorescent probe is crucial for achieving
subdiffraction resolution in fluorescence localization
microscopy (29). Most fluorescent markers used in single-
molecule-switching-based nanoscopies can be classified
into two main groups, photoswitchable fluorescent proteins
and organic dyes. Although proteins have the unique advan-
tage of being genetically encoded, they are not the most
suitable choice for the study of AS aggregates. Previous
reports suggest that fusion of a relatively large visible fluo-
rescent protein (e.g., ~27 kDa for a GFP) to AS (14 kDa) canperturb the native properties of the amyloid protein (16,30).
In contrast, organic dyes are much smaller than fluorescent
proteins (typically 500–800 Da), and they usually have the
additional advantage of being brighter and more photostable
than photoswitchable proteins. Therefore, many efforts have
been devoted to the synthesis of small organic molecules
with controllable switching properties suitable for stochastic
imaging approaches (31,32).
One family of rhodamine spiroamide (RSA) derivatives
(33–35) was recently developed for single- or dual-color
superresolution imaging (see Supporting Material). Upon
exposure to ultraviolet (UV) light, these compounds exhibit
the remarkable photophysical property of switching from
a dark isomer to a fluorescent species through a ring-opening
reaction of the five-member cycle containing the amide and
the spirocarbon atom. The switching can be tuned by adjust-
ment of the irradiance so that only a limited number of
molecules are activated during each frame period, such that
the corresponding emissions can be resolved without signif-
icant spatial overlap. RSAs offer some advantages over other
organic probes used in superresolution microscopy. They
display a simple and reliable switching mechanism that
requires only low-intensity near-UV irradiation (~375 nm).
In addition, proper switching of RSAs, unlike other markers
used in similar techniques, does not rely on the presence of
additional external chemical species such as oxygen scaven-
gers (enzymes, polyvinyl alcohol), thiols, redox active
species (e.g.. ascorbic acid, methyl viologen) (36), or a
second nearby chromophore acting as a blinking facilitator
(the activator) (37), which are not always compatible with
the sample or the conditions of the experiment. Furthermore,
these compounds have been derivatized with chemical
groups that allow coupling with proteins or other biomole-
cules: N-hydroxysuccinimide ester (NHS) derivatives for
primary amine groups and maleimide derivatives for selec-
tive reaction with thiols of cysteine-containing polypeptidic
chains. In view of these properties, RSAs make suitable
candidates for superresolution imaging of AS aggregation.
Here, we report the application of covalent labeling with
RSA probes coupled with PALM microscopy in studies of
AS amyloid aggregation both in vitro and in cells. We
evaluated the suitability of various RSA dyes for labeling
AS (AS-RSA) and optimized the aggregation conditions
so as to maintain unaltered the morphology of the fibrillated
structures, a condition assessed by AFM as a high-resolution
reference technique. AS fibrils prepared in vitro were then
imaged with subdiffraction fluorescence microscopy and
the resolution enhancement was compared with that of
conventional far-field microscopy and AFM. Furthermore,
the dual labeling of AS was introduced as a means of moni-
toring the propagation phase of aggregation at distinct
time points. Aggregation in cells was studied by microin-
jecting labeled AS, as in our previous reports based on a
tetracysteine-biarsenical expression probe (17,19,21,22)
in which the amyloid nature of the aggregates formedBiophysical Journal 102(7) 1598–1607
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morphology of discrete, intracellular subdiffraction-size
aggregates and generated estimates for the number of mono-
mers involved in such structures.MATERIALS AND METHODS
Protein labeling
AS was covalently labeled with compounds specifically developed
for PALM applications at the Department of Nanobiophotonics, Max Planck
Institute for Biophysical Chemistry, Go¨ttingen, Germany. These compounds
are derivatives of RSA and were chosen according to their emission pro-
perties and solubility in aqueous media. The selected compounds (Fig. S1
and Table S1 in the Supporting Material) were the sulfo-NHS derivative of
RSA577 and the NHS derivative of RSA617, previously reported in multi-
color imaging. The absorption maxima of the emitting open form are
570 nm and 600 nm, respectively, and the corresponding emission maxima
are 577 nm and 617 nm. In addition, we labeled AS with the NHS derivative
of the fluorescent Atto532 (ATTO-Tec, Siegen, Germany) for coinjection in
AS aggregation assays within cells, to allow a quick visual reference for
protein aggregation before superresolution imaging.
Protein labelingwas carried out using standard amine-coupling techniques.
Briefly, 1ml of a 135mMASsolution in 100mMNaHCO3buffer, pH8.3,was
mixed with the NHS fluorophore derivative stock in a 1:3.5 protein/fluoro-
phore molar ratio. The mixture was incubated at room temperature in an
orbital stirrer for 1 h. The unbound dye was removed by size-exclusion chro-
matography using a PD10column (Millipore,Billerica,MA), and the purified
labeled protein was concentrated using a centrifugal device (molecular mass
cutoff 3000 Da; Amicon, Millipore). The degree of labeling (DL), expressed
as the number of fluorophore molecules/AS monomer, was estimated by
absorbance measurements in a UV-visible spectrophotometer (Cary
UV100, Varian, Palo Alto, CA), and yielded a DL of ~3 for AS-RSA577,
AS-RSA617, and AS-Atto532 (estimated 10% error for DL).Superresolution microscopy
Single- and dual-color image acquisition were performed with a laboratory
instrument developed in the Nanobiophotonics Department. For dual-color
acquisition, a beam splitter with a DM570 dichroic mirror (Chroma,
McHenry, IL) was employed to separate the AS-RSA577 and AS-
RSA617 emissions. For each sample, we acquired ~50,000–70,000 frames
(acquisition time 10 ms/frame), and the image was reconstructed with
a pixel size of 15 nm. The experimental setup (34), acquisition sequence,
and image generation routine are described elsewhere (34,38). The image
size was 12 12 mm for single-color images, and 10  5 mm for dual-color
images. Image processing was then performed using MATLAB (The
MathWorks, Natick, MA) and Imspector (Imspector Image Acquisition &
Analysis Software, v0.1, http://www.imspector.de). For detailed informa-
tion, see the Supporting Material.Preparation of AS fibrils
For AS fibrillation, 400 ml of a 300 mM labeled AS solution in aggregation
buffer (20 mM Tris-HCl, pH 7.7, 100 mM NaCl, and 0.02% NaN3) were
placed in 1.5-ml Eppendorf tubes and incubated overnight at 70C with
continuous agitation (350 rpm, Eppendorf Thermomixer, Eppendorf,
New York, NY). The labeled/unlabeled AS molar ratio was 1:3. Fibril
purification was carried out by removing a 50-ml aliquot of the aggregation
mixture, placing it in a 1.5 ml Eppendorf tube, and centrifuging in a table
top centrifuge (Eppendorf) at 13,000 rcf for 15min. The supernatantwas dis-
carded, and the pellet containing the fibrils was resuspended in 100 ml aggre-
gation buffer. The centrifugation/resuspension cycle was repeated twice.Biophysical Journal 102(7) 1598–1607The final pellet was resuspended in 50 ml aggregation buffer/1% PVA, and
the fibrils were subsequently deposited onto a glass coverslip as a thin film
using home-built spin coater (conditions: 15 ml sample, 7000 rpm, 2 min).
The double-labeled AS fibrils for the elongation experiments with dual-
color PALM detection were prepared by coincubating a 400-ml AS-RSA577
fibril suspension (equivalent monomeric AS concentration, 30 mM) with
50 mM monomeric AS-RSA617 using the same conditions described
above supplemented with 500 mM spermine to accelerate aggregation.
Fifty-microliter aliquots were removed at 30, 60, 180, and 360 min, puri-
fied, and mounted onto glass coverslips as described above. As a control,
a sample of fibrils was prepared by incubating monomeric AS-RSA577,
AS-RSA617, and unlabeled AS in a 1:1:6 molar ratio. In addition, the
samples were also subjected to SDS denaturation by incubating the aliquots
with 3 mM SDS at 95C for 5 min before the purification routine.Image analysis of AS distribution in two-color
labeled fibrils
The distribution of AS-RSA617 monomer along preformed AS-RSA577
fibrils was carried out as follows. A binary mask was defined for each fibril
and superimposed to the intensity image in the RSA577 and RSA617
channel. The corresponding intensities arising from the counts of single
molecules detected in each channel (I577 and I617, respectively) and percen-
tile signal of each channel compared to the total single molecules count
were estimated. In the experimental setup, the signal from RSA577 contrib-
uted to the signal in the RSA617 channel; this cross talk, estimated as a 10%
of the signal measured in the RSA577 channel, was used to correct the
RSA617 signal.Real-time AS elongation observed by AFM
microscopy
AFM imaging was performed using a Nanoscope IIIa microscope (Digital
Instruments, Santa Barbara, CA) with a liquid cell coupled to a home-built
temperature controller. A 90-ml sample containing purified AS fibrils in
aggregation buffer was placed on a freshly cleaved mica surface, and 10
ml of a 50 mM monomeric AS þ 500 mM spermine solution was added.
The working temperature was adjusted to 45C and images were acquired
by continuous scanning in tapping mode (acquisition time 2 min). Image
analysis was performed using the instrument software.Characterization of intracellular AS aggregates
HeLa cells were cultured on glass coverslips (Menzel, Germany) in
Dulbecco’s modified Eagle’s medium containing 4.5 g/l glucose, 10% fetal
calf serum, and 1% penicillin/streptomycin (complete medium). The
experiments were carried out by microinjecting monomeric AS into the
cell cytoplasm, as reported earlier (17), using a semiautomatic microinjec-
tion apparatus and Femtotips (Eppendorf). The stock solution consisted of
a mixture of AS-RSA577 and wild-type AS in a 1:3 molar ratio (total
protein concentration 100 mM). RSA577 is not fluorescent until irradiated;
thus, a small amount of AS labeled with the fluorescent dye Atto532-NHS
(AS-Atto532) was included in the stock solution to detect the occurrence
of aggregates by conventional confocal microscopy (Zeiss LSM 510
confocal microscope, Zeiss, Germany) before performing the superresolu-
tion imaging experiments (final AS-Atto532 concentration in the stock
solution, 5 mM; laser line excitation, 532 nm). The intracellular protein
concentration was estimated by assuming a 10-fold dilution of the micro-
injected protein stock solution (24). The initial distribution of protein,
monitored by AS-Atto532 fluorescence, was homogeneous, but at 48 h,
bright aggregates were evident in the cytoplasm and perinuclear region.
At that point, the cells were fixed in 4% phosphate-buffered saline/parafor-
maldehyde, mounted in Mowiol (Kuraray America, Pasadena, TX), and
then imaged. The diameter of aggregates was estimated using Imspector
Fluorescence Nanoscopy of Amyloid 1601by plotting the normalized intensity profiles and measuring the corre-
sponding full width at half-maximum (FWHM) (sample set, n > 20).
The aggregates with diameters <40 nm were classified as subdiffraction
small aggregates (diameter estimated for oligomeric species of AS), and
the aggregates with diameters between 40 nm and the confocal resolution
were classified as medium-sized aggregates.
In addition, thioflavin S (ThioS) staining was performed to check the
amyloid nature of the aggregates. To that end, cell samples prepared in
parallel with those to be examined by superresolution imaging, were fixed
with PFA 4% and stained using standard protocols for ThioS. Colocaliza-
tion images of AS-Atto532 and ThioS were acquired with the confocal
microscope. Atto532 was imaged using the DPSS 532 nm laser line for
excitation, and ThioS images were acquired by exciting the probe with
the 457-nm Ar-ion laser line.Quantitative analysis of the number of AS
molecules (mAS) in subdiffraction-sized
intracellular aggregates
Image processing was performed with Imspector and DIPImage. We
defined masks for the aggregates (isodata masks from DIPImage), and
measured the number of single molecules present, assuming that it should
correspond closely to the AS monomers in view of the DL of ~3 and the
labeled AS/unlabeled AS molar ratio of 1:3 for the microinjected solution.
The mAS values for small aggregates were plotted as a histogram. From the
mAS values of medium-sized aggregates, the associated volume (Vagg) was
estimated assuming a spheroidal shape and the corresponding diameter
values estimated from the FWHM measurements. The differences between
the means of the diameters of the different batches of AS fibrils were sub-
jected to statistical evaluation with unpaired, two-tailed Student’s t-tests.
Data are reported as the mean 5 SE, with sample set sizes of n > 20
and P < 0.05.RESULTS AND DISCUSSION
Fluorescence labeling and superresolution
imaging of AS fibrils in vitro
We first characterized the features of amyloid structures
prepared in vitro (Fig. 1). We tested the optimal conditionsfor labeling AS with the NHS derivatives of rhodamine spi-
roamides RSA577 and RSA617 (34). The photophysical
properties of these probes are well characterized and their
suitability in two-color imaging experiments has been estab-
lished by standard immunolabeling of cellular structures
(see Materials and Methods and Supporting Material).
As indicated above, the probe size is a critical issue when
evaluating suitability for labeling the small (140-aa) AS
molecule. Therefore, we first assayed different AS-RSA
labeling conditions for the monomeric protein (see Mate-
rials and Methods for details), profiting from the chemical
reactivity of the side-group amines of lysines present in
AS toward NHS derivatives of the RSA probes. Of the 15
lysines that constitute the AS primary sequence, 11 are
located in the N-terminus of the protein, which is excluded
from the fibril core upon aggregation (39). We minimized
the potential perturbation of the AS aggregation properties
by reducing the RSA labeling ratio. From imaging experi-
ments of the purified AS monomers deposited on PVA films,
we determined that a ratio of 1:3 in the final product, i.e., the
labeled monomeric AS, maintained image quality and
preserved the structural integrity of AS. Thus, while the
localization of either 1:1 or 1:2 AS/RSA labeled monomers
was very difficult and produced very poor-quality images,
the 1:3 labeled monomers were adequately localized after
data acquisition and processing. Protein overlabeling
(i.e., a 1:10 labeled monomer) led to the precipitation of
AS during sample workup (data not shown). All of the
imaging experiments presented in the following sections
were performed with the 1:3 amino-labeled protein, here-
after referred to as AS-RSA577.
AS-RSA577 was subjected to aggregation experiments
to obtain labeled fibrils. It was necessary to coincubate
with unlabeled AS to obtain fibrils with normal morphology
(i.e., that of wild-type AS) while maintaining a sufficientFIGURE 1 Superresolution imaging of AS
fibrils prepared in vitro. (a) AFM images (height)
of wild-type AS fibrils (upper) and AS-RSA577
fibrils (lower) acquired in tapping mode. Scale
bar, 2.5 mm. (b) Superresolution image of AS
fibrils and aggregates prepared from monomeric
AS-RSA577. Scale bar, 2.5 mm; pixel size,
15 nm. (c) The corresponding wide-field image
was generated by superposing the acquired frames
without running any localization routine (same
scale bar). (d) The diameter of the fibrils was esti-
mated from the intensity profile across the fibrils
(green arrows) for superresolution images of two
selected fibrils. (e) Normalized intensity signal
across the fibrils highlighted in d. A mean diameter
of 245 4 nm was extracted from the FWHM data
(>20 fibrils measured).
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and Methods). With the optimal AS-RSA577/wild-type
AS labeling ratio of 1:3, the labeled fibrils had lengths
and diameters comparable to those of the unlabeled fibrils
(mean diameters by AFM, 9 5 2.1 nm and 9 5 1.8 nm,
respectively, n > 10) (Fig. 1 a). The AS-RSA577 fibrils
were purified and mounted in thin PVA films for fluores-
cence imaging. To focus the sample, the films were briefly
irradiated at 375 nm to generate a small population of the
probes in the emissive state. We acquired a sequence of
~50,000 frames (10 ms exposure time per frame) with an
excitation power at 532 nm of 18 kW cm2 in the focal
plane. The first 100–1000 images were measured without
photoinduced activation, i.e., by using the few spontaneously
activated molecules. We then increased the dose of the acti-
vating light as the number of remaining markers decreased.
The localization routine was applied to produce the final
image, and an associated synthetic wide-field image was
also created by superposing the raw frames (Fig. 1, b and
c). The subdiffraction images revealed an intricate net of
well-resolved fibrils in the entire field of view and it was
also possible to identify fibrils within the aggregates. In
contrast, the corresponding wide-field images lacked both
sharpness and resolution power. The diameter of the fibrils
spanned%2 pixels (pixel size, 15 nm) (Fig. 1 d). To quantify
the improvement in lateral resolution (Dr), we plotted
the normalized intensity profiles across the fibrils in the
subdiffraction images, measured the corresponding FWHM
values (Fig. 1 e), and referred the calculated mean to the
theoretical value according to Abbe’s limit (Dr ~ l/2 NA).
The mean diameter was 245 4 nm (n > 20), which repre-
sented an improvement in lateral resolution, Dr, to ~l/10.
We attribute the enhancement in resolution to 1), the
high number of RSA577 emitted photons, 2), the contrast
between the emitting isomers and those in the obscure
state, and 3), the reliable control of the switching of the
fluorescent probes. The observed difference between the
diameters estimated by AFM (~9 nm) and those estimated
by PALM (~24 nm) reflects the resolution attainable with
each technique.
We also carried out imaging experiments using AS-
RSA617, a monomer labeled with a rhodamine spiroamide
emitting at longer wavelengths than RSA577. The features
of AS-RSA617 fibrils were comparable to those obtained
with AS-RSA577 (data not shown).Assessing in vitro fibril elongation with two-color
subdiffraction fluorescence imaging
The successful implementation of AS labeling with a pair of
dyes suitable for two-color imaging (RSA577 and RSA617)
led to experiments of aggregation with both labels simulta-
neously, with the aim of characterizing the interaction
between monomeric and fibrillated AS and the behavior of
monomers during the elongation phase of the fibrils.Biophysical Journal 102(7) 1598–1607We had previously assessed in vitro fibril growth by
means of AFM imaging in solution (Fig. S2). Preformed
AS fibrils were deposited on a mica surface and incubated
with an excess of monomeric AS so as to shift the chemical
equilibrium toward fibril growth in the presence of 500 mM
spermine, a compound known to accelerate AS aggregation
(40,41). The elongation of the fibrils under the assay condi-
tions was assessed by scanning the surface at 2-min inter-
vals. After a brief lag time, the fibrils increased in length,
with an average linear elongation rate of ~2 5 1 nm/min
(Fig. S2). Superresolution microscopy allowed the exploita-
tion of the selectivity of fluorescence combined with the
ability to distinguish in situ preexisting monomer units in
the fibrils from those incorporated during the propagation
phase. Color separation was established using PVA films
containing monomeric AS separately labeled with
RSA577 (green channel) or RSA617 (red channel). There
was an ~10% cross-talk signal from RSA577 in the red
channel, but no signal from RSA617 was detected in the
green channel. We also prepared AS fibrils containing equi-
molar amounts of monomeric AS-RSA577 and AS-RSA617
to confirm that there was no preference for the inclusion of
either monomer in the amyloid structure. To that end, we
acquired images (Fig. S3), defined appropriate binary masks
for the regions delimiting the fibrils, and estimated the
percentage distribution of the total fluorescence signals in
the two channels. Each channel contributed ~50% to the
total fluorescence, in agreement with a random incorpora-
tion (i.e., independent of dye identity) of the labeled protein
into the fibril. Furthermore, the dual-color images presented
features indistinguishable from those obtained with single-
color labeling; the fibrils were several mm in length and
had diameters of ~20–30 nm.
For the fibril elongation experiments, we incubated AS-
RSA577 fibrils with monomeric AS-RSA617 in the
presence of 500 mM spermine (utilized in earlier AFM
experiments). We removed samples at 0, 30, 60, 180, and
360 min, purified the fibrils to eliminate excess AS-
RSA617, and imaged the fibrils mounted into thin PVA
films (Fig. 2). At t ¼ 0 min (green fibrils and red monomer
were mixed for <1 min and then purified), the fluorescence
signal of the fibrils was detected exclusively in the green
channel (after correcting for cross talk), indicating the pres-
ence of only RSA577 (Fig. 2 b) and ruling out a fast, unspe-
cific adsorption of free AS-RSA617 monomers onto the
amyloid structure. In contrast, a significant contribution
of AS-RSA617 was detected in the rest of the examined
samples (Fig. 2, c–f). To quantify this observation, we
segmented the images to define masks for the fibrils and
estimated the fractional distribution of each dye (Table 1).
The signal corresponding to AS-RSA617 was ~40% in all
cases, and the label was evenly distributed along the fibrillar
structure. This contribution did not disappear after incu-
bating the samples with SDS, which reportedly dissociates
AS fibrils at >2 mM concentration (42), suggesting the
FIGURE 2 Two-color imaging of AS fibril elon-
gation in vitro. (a) AS fibrils labeled with RSA577
observed by two-color superresolution imaging
before mixing with AS-RSA617 monomer.
Samples containing the preformed AS-RSA577
fibrils were then incubated with monomeric AS-
RSA617 (red). (b–f) Aliquots were withdrawn at
t ¼ 0 (b), 30 (c), 60 (d), 180 (e), and 300 min (f)
and imaged using a two-channel detection array.
Left column (green), RSA577 channel; center
column (red), RSA617 channel; right column,
channel overlay. Scale bar, 2.5 mm. (g) Detail of
fibril growth in samples corresponding to t ¼ 30
(left) and 60 (right) min. Scale bar for insets,
3 magnification of original image.
Fluorescence Nanoscopy of Amyloid 1603occurrence of interactions or interchange mechanisms
between AS in solution and fibrils. Furthermore, close
inspection of the images revealed the presence of anchor
points from which fibrils propagated from a preexisting
structure (Fig. 2 g). These extensions were formed almost
exclusively by AS-RSA617 monomers (>90% of the
secondary fibrillar segments were assigned to the red
channel). A noteworthy observation is that growth wasTABLE 1 Fractional distribution of AS-RSA577 and AS-
RSA617 signals in AS fibril elongation imaging assays
Sample % AS-RSA577 % AS-RSA617
AS-RSA577 alone 905 2 105 2
0 min 935 1 75 1
30 min 425 3 585 3
60 min 415 3 595 3
180 min 415 3 595 3
300 min 485 4 525 4unidirectional, i.e., the fibrils elongated only from one end
of the structure, a feature previously described for the
growth of amyloid Ab peptide fibrils (43). From the length
of the fibrils originating from the anchor points, we esti-
mated a fibril growth rate of ~7 5 4 nm/min.Subdiffraction imaging of intracellular
aggregates
The improvement in resolution observed in the experiments
performed in vitro led us to a corresponding study of AS
aggregation in cells. To that end, we microinjected AS-
RSA577 mixed with wild-type AS in a 1:3 molar ratio
(total protein concentration 100 mM) into HeLa cells and
incubated them for 48 h at 37C. Due to the lack of fluores-
cence of the closed form of AS-RSA577, we coinjected
a small amount (~5 mM) of AS labeled with Atto532 (AS-
Atto532) to monitor the occurrence of aggregates usingBiophysical Journal 102(7) 1598–1607
1604 Roberti et al.confocal microscopy. Aggregation proceeded with the
development of spheroidal, perinuclear, highly fluorescent
aggregated structures (Fig. 3 a), as we previously reported
using a tetracysteine expression tag for AS (17,19,21,22).
The amyloid nature of the aggregates was confirmed by
ThioS staining of cell samples prepared in parallel (data
not shown), since ThioS is a dye specific for the identifica-
tion of amyloid structures in tissue. We distinguished two
types of aggregates according to size—micrometer-sized
aggregates, with diameters on the order of micrometers,
and subdiffraction-sized aggregates, with apparent diame-
ters close to the confocal resolution (~200 nm), which could
not be resolved by conventional imaging. Once protein
aggregation was confirmed, the cells were fixed and
mounted. Superresolution images were acquired after the
Atto532 was completely bleached.
We focused our attention on the subdiffraction aggregates
in view of their potential cytotoxicity. They appeared similar
by conventional far-field microscopy. The probe activation
conditions yielded a distribution of single-molecule events
sufficiently sparse for good imaging. In the case of the large,
micrometer-sized aggregates, the probe density was exces-
sive, such that it was not possible to activate and excite
single molecules as required by the stochastic principle.
Therefore, such large aggregates were not imaged under
superresolution conditions. However, in contrast to previous
reports of in vitro studies (8,10), we did not observe single
fibrils emerging from such aggregates. Had fibrils withFIGURE 3 Characterization of intracellular subdiffraction-size AS aggrega
a mixture of monomeric AS-Atto532, AS-RSA577 (nonfluorescent under the im
views of the presence of subdiffraction-sized (yellow arrow) and micrometer-siz
(b and c) Subdiffraction resolution image of aggregated AS in a cytoplasmic re
2.5 mm, pixel size, 15 nm. (d) Detailed view of a subdiffraction small aggrega
(diameter 40–200 nm) (right) extracted from b. Scale bar, 4 magnification of o
gates depicted in d. (f) Histogram of the number of AS monomers (mAS) in smal
subdiffraction medium-sized aggregates. Linear fit to the data (R2 ¼ 0.85).
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length) been present, they would have been discerned due
to the lower local concentration of dye in individual fibrils
as displayed in our superresolution in vitro assays.
The resolution of our setup allowed us to perceive
the subdiffraction-sized aggregates with a resolution of
~15 nm (Fig. 3, b and c). The structures were round in shape
and were assigned to two distinctive subgroups based
on size: subdiffraction small aggregates with diameters
of <40 nm, and subdiffraction medium-sized aggregates
with diameters in the range 40–200 nm, estimated from
FWHM intensity profile measurements (Fig. 3, d and e).
These two distinct types of structure bore striking resem-
blance to some of the nonamyloid (i.e prefibrillar) supramo-
lecular colloidal species our laboratories and colleagues
have recently observed in vitro using AFM and cryo-ET
(8). These include early colloidal supramolecular associates
(fuzzy balls) with an apparent diameter of ~30 nm, and the
acunas (amyloid þ cuna, the Spanish word for cradle) with
diameters of up to 200–600 nm.
To further characterize these detected structures, we
exploited the underlying principle of single-molecule local-
ization to estimate the number of AS units (mAS) in the
subdiffraction structures. Our calculations involved the
following conditions: 1), a 1:3 mixture of AS-RSA577/
unlabeled (i.e., wild-type) AS was microinjected; 2),
the DL of AS was ~3; and 3), the distribution of labeled
markers within the aggregates was random. It is importanttes. (a) Conventional confocal image of HeLa cells microinjected with
aging conditions), and wild-type AS. Scale bar, 25 mm. (Insets) Detailed
ed (green arrow) aggregates. Scale bar, 4 magnification of original image.
gion of the cell (b) and the corresponding wide-field image (c). Scale bar,
te (diameter <40 nm) (left) and a subdiffraction medium-sized aggregate
riginal image. (e) Normalized intensity profiles corresponding to the aggre-
l aggregates. (g) Correlation between mAS and the corresponding volume of
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mated, partly because not all labeled molecules would
have been activated, and also because some of the activated
molecules may have been discarded in the thresholding step
of the localization routine (26,34,38). The analysis resulted
in an estimated mAS of <100 AS monomers in the small
aggregates. The histogram of mAS values was centered at
~70 monomers/aggregate (Fig. 3 f). These results are
compatible with descriptions of transient intracellular AS
oligomers (see above) but using calculations based exclu-
sively on indirect determinations in vitro (8), as in the
case of the aforementioned fuzzy balls. In contrast, the
medium-sized aggregates contained hundreds and even
thousands of AS units, and are most probably correlated
with the higher-order structures, the acunas. From the exper-
imental data, we infer a roughly linear correlation between
the number of AS monomers and the calculated volume of
the aggregates (Vagg) (Fig. 3 g), assuming the accuracy
of the diameter estimations and a spheroidal shape. In the
event that the activation/detection efficiency in the axial
direction over the range of particle dimensions was constant
under our experimental conditions, such that all molecules
were detected with equal probability, we can estimate
from the data a volume/aggregated AS monomer of ~500–
900 nm3 (Fig. 3, f and g). A hydrodynamic radius of
~3 nm for partially compacted AS monomers would corre-
spond to a value of ~110 nm3. We tentatively conclude that
during the presumed colloidal phase of AS association, AS
maintains a constant but relatively low mean density consis-
tent with the heterogeneous supramolecular nanostructures
revealed by cryo-ET in vitro (8).CONCLUSIONS
The experiments featured in this report offer promising
perspectives for the investigation of the molecular mecha-
nisms of amyloid formation both in vitro and in the cellular
milieu. By using AS covalently functionalized with the
selected dyes, we obtained labeled fibrils that conserved
the morphology of those prepared from unlabeled protein.
Direct labeling of AS offers an additional advantage com-
pared to the use of immunofluorescence, considering the
small size of both the monomeric protein and the amyloid
structures. As an example, according to fluorescence nano-
scopy experiments on cells stained with a tubulin-targeted
primary antibody and a fluorescently labeled secondary
antibody, the diameter of tubulin fibrils is ~70 nm, compared
to ~30 nm reported by EM (44). The 70-nm value reflects
the contribution of the diameter of the fibril and that of
the bulky biomolecules employed for immunostaining.
Superresolution microscopy reveals more accurately the
size of the structure of interest. In vitro, we achieved a Dr
of ~10 times below the classical limit. The diameters of
the amyloid fibrils were estimated at ~20–30 nm, and it
was possible to visualize individual fibrils within the denseaggregates. The double labeling experiments revealed
terminal elongation of preexisting fibrils and initiation of
branches from internal anchor points. These findings are
in agreement with observations made by AFM imaging
for the amyloid Ab peptide (45), and the complementary
data provide what to our knowledge are new insights into
the kinetics and mechanistic aspects of fibril elongation.
The elongation rate determined from the propagation ex-
periments with the fluorescently labeled AS was in good
agreement with that estimated by AFM. The value from
the superresolution images has a higher uncertainty due to
the fact that the measurements were not recorded continu-
ously (as by AFM). We also detected the adsorption of
freshly added monomer along the entire extent of resolved
fibrils, indicating the existence of an exchange mechanism
between fibrillated and free AS under the conditions of
incubation, attesting further to the dynamic nature of the
system.
It is possible to adapt and extend the assay to the study of
AS interactions with other proteins and to the effects of
agents promoting or inhibiting aggregation. Multicolor
labeling also facilitates the detection of intermediate species
involved in the aggregation process but invisible with ultra-
resolution techniques such as AFM and EM. Other amyloid
proteins have been studied previously with total internal
reflection fluorescence (TIRF) microscopy (46) using ThioT
as the fluorescent label, but the approach is limited because
ThioT is easily photobleached and exhibits fluorescence
only at the stage of fibrillation; in addition, the lateral
TIRF resolution is that of conventional fluorescence micros-
copy. The superresolution technique combined with TIRF
achieves improvements in both lateral and axial resolution,
as demonstrated in a recent study of intermediate and fibril-
lated stages of the Alzheimer’s-disease-related Ab peptide
in vitro and within cells (47). In another report, the
combination of AFM and fluorescence blink microscopy
elucidated structural features of Huntingtin protein aggre-
gates (48).
The experiments with cells revealed for the first time
fluorescence images of discrete, small spheroidal structures
that characterize the early stages of AS aggregation. The
apparent diameter of such species when using conventional
fluorescence microscopy is ~200 nm, compared to ~40 nm
using PALM. Previous reports of AS oligomers in the
cellular context provided only indirect evidence for such
species. These investigations were based on AFM and EM
microscopy of in vitro preparations and the analysis of
cellular lysates by chromatography (49,50). The dimensions
of the small spheroids visualized by superresolution micros-
copy are in good agreement with the estimates of ~24–
34 nm using EM (49). However, a more compelling correla-
tion is between the subdiffraction small and medium-sized
aggregates and the supramolecular structures, fuzzy balls
and acunas, recently discerned by combined AFM and
cryo-ET. Under the proposed sequential association schemeBiophysical Journal 102(7) 1598–1607
1606 Roberti et al.for AS colloidal intermediates (8,51), nonamyloid structures
result from an initial condensation of monomeric or pauci-
oligomeric AS. They subsequently collapse into thermody-
namically more stable supramolecular assemblies with the
unique capacity for promoting the formation of linear cate-
nations maturing to the classical amyloid fibrils featured in
Figs. 1 and 2. It is important to note that with the exception
of Lewy bodies, there are no reports in the literature of the
presence of canonical AS amyloid fibrils within mammalian
cells; AS aggregates rather appear as punctuate inclusions
(52–54) similar to those presented in this study.
In view of the constant development of fluorescence
nanoscopies, we anticipate significant further improvements
in achievable resolution and acquisition speed (55),
enabling the monitoring of aggregation and structural
transitions in real time and in living cells. In the latter
case, fluorescent expression systems are required that can
fulfill the dual requirements of preservation of AS molecular
integrity and suitability for the superresolution micros-
copies. One possibility lies in the development of more
photostable fluorogenic biarsenical compounds for use
with the tetracysteine AS expression system (56).SUPPORTING MATERIAL
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